Kane Biotech to Participate in a Multinational Corporate Collaboration Project

“DispersinB® is an elegant and potentially disruptive technology that is attracting a lot of attention from industry leaders. This funding will allow us to accelerate the development of our DispersinB® Wound Gel with the support of one of the largest wound care companies in the world, while simultaneously helping to level the playing field financially. We are looking forward to the outcome of the collaboration between these world-class teams of researchers, on this important project,” said Marc Edwards, President & CEO. “I would like to thank NRC IRAP for supporting Kane’s participation in this international collaboration project.” Read More

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

Kane Biotech to Participate in a Multinational Corporate Collaboration Project